Viewing SEC Facts Units
Company Name:
PRELUDE THERAPEUTICS INC
CIK:
1678660
Start Filing Date:
2023-04-01
End Filing Date:
2023-06-30
ACCN:
0000950170-23-037611
Value:
$ 9,357,000
Value Error:
$ None
Created By:
Date Filed:
2023-08-03
FY:
2023
Fiscal Period:
Q1
Frame:
CY2023Q2I
Type:
us-gaap
Form:
10-Q
Units:
USD